In this interview, CEO Martin Gouldstone of Oncimmune - a global leader in immune biomarkers and immunodiagnostics – takes Vox Markets through:
00:00 His first impressions of the business & how ONC's services are used in the field.
07:00 Revised commercial strategy
17:45 Current health of the sector
21…
Hot Stocks
Stocks to Follow
Stock Market
Investing
AIM
Money
Equities
Markets
ONC
Oncimmune